Table 2.
Result of FoundationACT™ in a 34-year-old female former smoker with advanced lung adenocarcinoma
Blood (collected and submitted in 2016) | |
Alterations | Mutation allele frequency |
MET 3028+2T>C (splice site mutation) | 0.19% |
BRCA2 L3061* | 50.7% |